FDA Requests Public Comment on Proposed Collection of Information for Biologics License Applications

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, which includes general licensing provisions for biologics license applications and other related matters.